Fig: Absorption of Dexmeditomidine
The European Union has not yet given it the go-ahead. Patients undergoing heart and
Vascular surgeries have been the majority of those who have participated in clinical trials using Dexmeditomidine. It is critical to accurately identify patients and administer adequate medication in order to avoid serious hemodynamic damage. Even after 20 minutes of moderate bolus loading, the heart rate and blood pressure are only slightly lower than they were before.
The use of Dexmeditomidine during general anesthesia can be beneficial in a variety of ways, including awake fibre optic intubation, reducing the amount of hypnotic and opioid medications required, preventing postoperative pain, nausea, vomiting, and shivering, and improving postoperative sleep and recovery. Aside from that, the anti-inflammatory properties of the medication have been found to cause bradycardia in certain individuals.